Moreover, the half-life assays showed that HBXIP overexpression could obviously suppress the degradation of HIF1α (Figure 4E), suggesting that HBXIP contributes to the stability of HIF1α in breast cancer cells. The gene discussed is HIF1A; the disease is breast cancer.